文献速递免疫规划

预防性或治疗性使用对乙酰氨基酚对印度婴儿DTwP-HepB-Hib联合疫苗免疫应答的影响

Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
PubMed 文献 · Vaccine · 2017-04-24

该研究为一项印度五价疫苗临床试验的事后分析,比较未用对乙酰氨基酚组与用药组(进一步分为预防性用药组和治疗性用药组)婴儿接种DTwP-HepB-Hib联合疫苗前后的抗体水平。结果显示各组抗D、抗T、抗wP、抗PT、抗HBs和抗PRP的血清保护/血清应答率及几何平均滴度均相似,无明确差异趋势。结论认为未发现对乙酰氨基酚预防性或治疗性使用影响该联合疫苗免疫应答的证据。

要点

  • 各组抗D、抗T、抗wP、抗PT、抗HBs和抗PRP血清保护/血清应答率相似。
  • 各组血清保护/血清应答百分比及几何平均滴度无明确差异趋势。
  • 未发现对乙酰氨基酚预防性或治疗性使用影响该联合疫苗免疫应答的证据。

核心结论

  • 研究未发现对乙酰氨基酚预防性或治疗性使用影响DTwP-HepB-Hib联合疫苗免疫应答的证据。

研究设计与样本

  • 本报告为印度婴儿五价疫苗临床试验的事后分析,比较未用对乙酰氨基酚组与对乙酰氨基酚组(进一步分为预防性用药组和治疗性用药组)接种前后针对白喉、破伤风、百日咳、乙型肝炎、B型流感嗜血杆菌的抗体水平。

主要发现

  • 各组抗D、抗T、抗wP、抗PT、抗HBs和抗PRP的血清保护/血清应答率相似。
  • 各组血清保护/血清应答百分比及几何平均滴度无明确差异趋势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccination is considered as the most cost effective method for preventing infectious diseases. Low grade fever is a known adverse effect of vaccination. In India, it is a common clinical practice to prescribe paracetamol either prophylactically or therapeutically to manage fever. Some studies have shown that paracetamol interferes with antibody responses following immunization. This manuscript reports the outcome of a post hoc analysis of data from a clinical trial of a pentavalent vaccine in Indian infants where paracetamol was not used or was used either as prophylaxis or for treatment of fever. METHODS: Pre and post vaccine antibody levels against Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenzae type B were assessed in no paracetamol and paracetamol groups. The paracetamol group was further divided into prophylactic and treatment groups. RESULTS: Similar rates of seroprotection/seroresponse for anti-D, anti-T, anti-wP, anti-PT, anti-HBs and anti-PRP were observed in all the groups. There was no clear tendency for difference in percentage seroprotection/seroresponse and geometric mean (GM) titers in any of the groups. CONCLUSION: The study found no evidence that paracetamol usage either as prophylactic or for treatment impact immunological responses to DTwP-HepB-Hib combination vaccine. [Clinical trial registry of India (study registration number CTRI/2012/08/002872)].

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sil A, Ravi MD, Patnaik BN, et al. Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants. Vaccine. 2017. PMID: 28449972. doi:10.1016/j.vaccine.2017.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。